By Michael MacManus, MD, FRANZCR, and Tim Akhurst, MD, FRACP Posted: March 1, 2019 Dr. Michael MacManus 18F-FDG PET/CT scans portray living biology and are indispensable in thoracic oncologic evaluations, […] Read more
Posted: March 1, 2019 Adi Gazdar, MD, a true giant in the field of lung cancer research, passed away on December 29, 2018. Dr. Gazdar was the W. Ray Wallace […] Read more
By Karen L. Reckamp, MD, MS Posted: March 1, 2019 Dr. Karen L. Reckamp Identification of genetic alterations in NSCLC has transformed diagnosis and treatment for patients with advanced disease. […] Read more
By Carolyn M. Dresler, MD, MPA Posted: March 1, 2019 It is common knowledge that the number one cause of preventable deaths in the world is from tobacco use—overwhelmingly from […] Read more
By Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE Posted: March 1, 2019 There was a time, remembered by us older pathologists, when the image of pathology was that of a […] Read more
By DR CamidgePosted: March 1, 2019 The National Cancer Institute featured a workshop in June 2018 titled “At the Crossroads of Social Media and Clinical Trials: A Workshop on the […] Read more
Posted: March 1, 2019 In the following interview, Jamie E. Chaft, MD, a medical oncologist at the Memorial Sloan Kettering Cancer Center, discusses new data on induction immunotherapy for patients […] Read more
By Stephen V. Liu, MD Posted: March 1, 2019 Dr. Stephen V. Liu The addition of atezolizumab to standard chemotherapy for extensive-stage SCLC achieved what, for decades, had been beyond […] Read more
By Doreen A. Ezeife, MD, FRCPC; Malcolm Ryan; and Natasha B. Leighl, MD, MMSc, FRCPC, FASCO Posted: March 1, 2019 Dramatic improvements in lung cancer outcomes can be attributed to […] Read more
Posted: March 1, 2019 Federico Cappuzzo, MD, PhD, has been the director of Medical Oncology at AUSL della Romagna, Ravenna, Italy, since April 2016; in January 2017 he became the […] Read more